Daniel Kreps
Contact Daniel Kreps on X Contact Daniel Kreps by Email View all posts by Daniel Kreps April 18, 2026
(L/R) FDA Commissioner Marty Makary, Health Secretary Robert F. Kennedy Jr., US media personality Joe Rogan, W. Bryan Hubbard, CEO of Americans for Ibogaine, and former Navy SEAL Marcus Lutrell applaud after US President Donald Trump signed an executive order in the Oval Office of the White House in Washington, DC on April 18, 2026. Jim Watson/AFP via Getty Images Following a text from Joe Rogan, President Donald Trump signed an executive order Saturday to hasten the research of psychedelics use to treat mental health disorders.
The podcaster joined the president at the White House Saturday for the signing of the order, which will push the Food and Drug Administration to fast-track its review of psychedelics like Ibogaine as part of treatment for military veterans suffering from post-traumatic stress disorder, Reuters reports.
“Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life,” Trump said.
The research could pave the way for some now-illegal psychedelics to be reclassified if the trials are successful. “I’ve been hearing about it a little bit over the last year,” Trump added of psychedelics being used to treat PTSD. “I never heard anything about it in the past. It was almost like, taboo. It’s not taboo anymore.”
Saturday’s executive order came after Rogan texted the president to lobby about psychedelics. “I sent him that information. The text message that came back: ‘Sounds great. Do you want FDA approval? Let’s do it.’ Literally that quick,” Rogan said in the Oval Office on Saturday.
